Method for predicting responsiveness to a pharmaceutical...

Details Method for predicting responsiveness to a pharmaceutical... Method for predicting responsiveness to a pharmaceutical...

G - Physics

01

N

G01N 33/92 (2006.01)

Patent

CA 2710395

Methods for using TRL V6 as a biomarker for the modulation of triglyceride and/or lipoprotein metabolism in a mammal induced by a weight loss pharmaceutical agent. The biomarker may be used for determining if an individual patient will likely respond favorably to a given weight loss pharmaceutical agent.

L'invention porte sur des procédés d'utilisation du TRL V6 comme biomarqueur pour la modulation d'un métabolisme de triglycéride et/ou de lipoprotéine chez un mammifère induit par un agent pharmaceutique de perte de poids. Le biomarqueur peut être utilisé pour déterminer si un patient individuel sera susceptible de répondre de manière favorable à un agent pharmaceutique de perte de poids donné.

Affiliated with

Also associated with

Rating

Method for predicting responsiveness to a pharmaceutical... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for predicting responsiveness to a pharmaceutical..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for predicting responsiveness to a pharmaceutical... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1930647